Evidence map›Paper›PMID 41070685›Full record

ArticleChemical research in toxicology2025

Metabolic Profile of Male Cannabis Users and Estimation of Candidate Biomarkers.

Esin Oz, Merve Kasikci, İbrahim Celik, Mukaddes Gurler

Abstract read
In one paragraph

Article in Chemical research in toxicology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Esin OzDepartment of Medical Biochemistry, Faculty of Medicine, Hacettepe University, Ankara 06100, Turkey.ORCID 0000-0002-0074-9471
Merve KasikciDepartment of Biostatistics, Faculty of Medicine, Hacettepe University, Ankara 06100, Turkey.
İbrahim CelikFaculty of Medicine, Hacettepe University, Ankara 06100, Turkey.
Mukaddes GurlerDepartment of Medical Biochemistry, Faculty of Medicine, Hacettepe University, Ankara 06100, Turkey.ORCID 0000-0001-9431-9810

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Tetrahydrocannabinol (THC), the primary psychoactive compound of cannabis, is the most widely abused substance worldwide, with an annual prevalence of 4.3% of adults and 5.3% of the 15-16 year-old population estimated as of 2022. THC has both acute and chronic effects through the dopaminergic and endocannabinoid systems. This study was conducted to better understand the metabolites and metabolic pathways in biological systems affected by cannabis, which may help find practical diagnostic and treatment approaches for people with cannabis dependence in the future. Metabolomic analysis of urine samples was performed using gas chromatography-mass spectrometry (GC-MS). MetaboAnalyst software was used to determine sample metabolite profiles, which were then subjected to multivariate statistical analysis. From data of over 200 metabolites in each sample of cannabis users, 92 metabolites with a

Indexed as

CannabisMetabolomeAdolescentAdultBiomarkersGas Chromatography-Mass SpectrometryHumansMaleMetabolomicsYoung AdultBiomarkers

Identifiers

PMID41070685
PMCPMC12541800

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.